Cyclopropenium Nanoparticles and Gene Transfection in Cells.
Noam Y SteinmanLuis M CamposYakai FengAbraham J DombHossein HosseinkhaniPublished in: Pharmaceutics (2020)
Non-viral vectors for the transfection of genetic material are at the frontier of medical science. In this article, we introduce for the first time, cyclopropenium-containing nanoparticles as a cationic carrier for gene transfection, as an alternative to the common quaternary ammonium transfection agents. Cyclopropenium-based cationic nanoparticles were prepared by crosslinking poly(ethylene imine) (PEI) with tetrachlorocyclopropene. These nanoparticles were electrostatically complexed with plasmid DNA into nanoparticles (~50 nm). Their cellular uptake into F929 mouse fibroblast cells, and their eventual expression in vitro have been described. Transfection is enhanced relative to PEI with minimal toxicity. These cyclopropenium nanoparticles possess efficient gene transfection capabilities with minimal cytotoxicity, which makes them novel and promising candidates for gene therapy.
Keyphrases
- gene therapy
- induced apoptosis
- genome wide
- copy number
- cell cycle arrest
- escherichia coli
- healthcare
- poor prognosis
- walled carbon nanotubes
- gene expression
- genome wide identification
- photodynamic therapy
- signaling pathway
- endoplasmic reticulum stress
- transcription factor
- ionic liquid
- cell free
- crispr cas
- binding protein
- genome wide analysis